Source:http://linkedlifedata.com/resource/pubmed/id/21743439
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
15
|
pubmed:dateCreated |
2011-8-3
|
pubmed:abstractText |
Prion diseases are associated with the conversion of cellular prion protein (PrP(C)) to toxic ?-sheet isoforms (PrP(Sc)), which are reported to inhibit the ubiquitin-proteasome system (UPS). Accordingly, UPS substrates accumulate in prion-infected mouse brains, suggesting impairment of the 26S proteasome. A direct interaction between its 20S core particle and PrP isoforms was demonstrated by immunoprecipitation. ?-PrP aggregates associated with the 20S particle, but did not impede binding of the PA26 complex, suggesting that the aggregates do not bind to its ends. Aggregated ?-PrP reduced the 20S proteasome's basal peptidase activity, and the enhanced activity induced by C-terminal peptides from the 19S ATPases or by the 19S regulator itself, including when stimulated by polyubiquitin conjugates. However, the 20S proteasome was not inhibited when the gate in the ?-ring was open due to a truncation mutation or by association with PA26/PA28. These PrP aggregates inhibit by stabilising the closed conformation of the substrate entry channel. A similar inhibition of substrate entry into the proteasome may occur in other neurodegenerative diseases where misfolded ?-sheet-rich proteins accumulate.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1460-2075
|
pubmed:author |
pubmed-author:AndréRalphR,
pubmed-author:CollingeJohnJ,
pubmed-author:DeriziotisPelagiaP,
pubmed-author:GlickmanMichael HMH,
pubmed-author:GoldbergAlfred LAL,
pubmed-author:GooldRobR,
pubmed-author:KinghornKerri JKJ,
pubmed-author:KristiansenMarkM,
pubmed-author:KrutauzDashaD,
pubmed-author:NathanJames AJA,
pubmed-author:RosenzweigRinaR,
pubmed-author:SmithDavid MDM,
pubmed-author:TabriziSarah JSJ
|
pubmed:issnType |
Electronic
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3065-77
|
pubmed:dateRevised |
2011-10-7
|
pubmed:meshHeading |
pubmed-meshheading:21743439-Animals,
pubmed-meshheading:21743439-Humans,
pubmed-meshheading:21743439-Immunoprecipitation,
pubmed-meshheading:21743439-Mice,
pubmed-meshheading:21743439-Mice, Transgenic,
pubmed-meshheading:21743439-Models, Molecular,
pubmed-meshheading:21743439-PrPSc Proteins,
pubmed-meshheading:21743439-Proteasome Endopeptidase Complex,
pubmed-meshheading:21743439-Protein Binding,
pubmed-meshheading:21743439-Protein Interaction Mapping
|
pubmed:year |
2011
|
pubmed:articleTitle |
Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry.
|
pubmed:affiliation |
Department of Neurodegenerative Disease, University College London Institute of Neurology, Queen Square, London, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|